Continuum Advisory, LLC Moderna, Inc. Transaction History

Continuum Advisory, LLC

  • $680 Million
  • Q2 2024

A detailed history of Continuum Advisory, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 146 shares of MRNA stock, worth $9,221. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146
Previous 138 5.8%
Holding current value
$9,221
Previous $14,000 21.43%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
BUY
$101.21 - $166.61 $809 - $1,332
8 Added 5.8%
146 $17,000
Q1 2024

May 10, 2024
BUY
$85.37 - $115.44 $11,781 - $15,930
138 New
138 $14,000
Q3 2023

Nov 13, 2023
SELL
$96.41 - $126.61 $20,728 - $27,221
-215 Reduced 8.88%
2,206 $227,000
Q2 2023

Dec 13, 2023
SELL
$118.5 - $160.53 $72,996 - $98,886
-616 Reduced 20.28%
2,421 $294,000
Q2 2023

Aug 10, 2023
SELL
$118.5 - $160.53 $72,996 - $98,886
-616 Reduced 20.28%
2,421 $294,000
Q1 2023

Dec 13, 2023
SELL
$135.66 - $197.02 $43,953 - $63,834
-324 Reduced 9.64%
3,037 $466,000
Q1 2023

May 12, 2023
SELL
$135.66 - $197.02 $43,953 - $63,834
-324 Reduced 9.64%
3,037 $466,000
Q4 2022

Dec 13, 2023
SELL
$118.38 - $210.04 $10,535 - $18,693
-89 Reduced 2.58%
3,361 $603,000
Q4 2022

Feb 10, 2023
SELL
$118.38 - $210.04 $10,535 - $18,693
-89 Reduced 2.58%
3,361 $603,000
Q3 2022

Dec 13, 2023
BUY
$118.07 - $194.18 $46,047 - $75,730
390 Added 12.75%
3,450 $407,000
Q3 2022

Nov 08, 2022
BUY
$118.07 - $194.18 $46,047 - $75,730
390 Added 12.75%
3,450 $408,000
Q2 2022

Dec 13, 2023
SELL
$117.13 - $176.59 $53,879 - $81,231
-460 Reduced 13.07%
3,060 $437,000
Q2 2022

Aug 15, 2022
SELL
$117.13 - $176.59 $53,879 - $81,231
-460 Reduced 13.07%
3,060 $437,000
Q1 2022

Dec 13, 2023
BUY
$126.46 - $235.05 $62,597 - $116,349
495 Added 16.36%
3,520 $606,000
Q1 2022

May 17, 2022
BUY
$126.46 - $235.05 $62,597 - $116,349
495 Added 16.36%
3,520 $473,000
Q4 2021

Dec 13, 2023
BUY
$225.82 - $368.51 $157,396 - $256,851
697 Added 29.94%
3,025 $768,000
Q4 2021

Feb 14, 2022
BUY
$225.82 - $368.51 $157,396 - $256,851
697 Added 29.94%
3,025 $768,000
Q3 2021

Dec 13, 2023
BUY
$221.9 - $484.47 $16,642 - $36,335
75 Added 3.33%
2,328 $895,000
Q3 2021

Nov 08, 2021
BUY
$221.9 - $484.47 $16,642 - $36,335
75 Added 3.33%
2,328 $896,000
Q2 2021

Dec 13, 2023
BUY
$129.91 - $234.98 $6,105 - $11,044
47 Added 2.13%
2,253 $529,000
Q2 2021

Aug 17, 2021
BUY
$129.91 - $234.98 $65,214 - $117,959
502 Added 28.67%
2,253 $529,000
Q1 2021

May 14, 2021
BUY
$109.18 - $185.98 $191,174 - $325,650
1,751 New
1,751 $280,000

Others Institutions Holding MRNA

# of Institutions
1,114
Shares Held
241M
Call Options Held
9.26M
Put Options Held
12.1M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $24.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email